Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

66.62

+0.39 (0.59%)

At close: Dec 5, 2025, 4:00 PM EST

71.71

+5.09 (7.64%)

After-hours: Dec 5, 2025, 7:52 PM EST

Kymera Therapeutics Employees

Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.

Employees

188

Change (1Y)

1

Growth (1Y)

0.53%

Revenue / Employee

$232,633

Profits / Employee

-$1,569,798

Market Cap

4.79B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	188	1	0.53%
Dec 31, 2023	187	20	11.98%
Dec 31, 2022	167	26	18.44%
Dec 31, 2021	141	66	88.00%
Dec 31, 2020	75	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

KYMR News

1 day ago - Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025 - GlobeNewsWire
3 days ago - Kymera Therapeutics, Inc. (KYMR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
11 days ago - Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader - GlobeNewsWire
12 days ago - Kymera Therapeutics to Participate in Upcoming December Investor Conferences - GlobeNewsWire
26 days ago - Kymera Therapeutics, Inc. (KYMR) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
4 weeks ago - Kymera Therapeutics, Inc. (KYMR) Q3 2025 Earnings Call Transcript - Seeking Alpha
4 weeks ago - Kymera Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
5 weeks ago - Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire